Corporate Banner
Satellite Banner
ADME Tox
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Reprocell Acquires Reinnervate and BioServe

Published: Tuesday, August 05, 2014
Last Updated: Tuesday, August 05, 2014
Bookmark and Share
The company group now offers products and services that spans 2D and 3D cell culture, stem cell culture media, iPSC-derived cells and human tissue samples.

Reinnervate Ltd has been acquired by Reprocell of Shin-Yokohama in Japan. Reprocell intends to combine it’s iPSC-derived cells with the Alvetex range of 3D cell culture products to produce and sell next-generation tools for drug toxicity testing, neuroscience and cancer research.

Reprocell also announced the acquisition of BioServe Inc of MD, USA, a leading supplier of human tissues and other biological samples with one of the largest commercial biorepositories in the world. BioServe also offer a range of services including, genotyping, gene expression and allelic discrimination (RT PCR).

Reprocell plans to use the unparalleled access to human tissues to generate a wide range of disease-related iPSC lines for production of human disease cell models.

Commenting on the deal, Reinnervate Ltd CEO. Richard Rowling, said ‘We are delighted to become part of the Reprocell group of companies and look forward seeing Alvetex products combined with Reprocell’s advanced stem cell derived cell products. Our customers are always looking for ways to improve the biological relevance of cell based assays and to move away from using cell lines. Combining the benefits offered by iPSC-derived cells and 3D cell culture will lead to exciting new product introductions’.

Chika Yokoyama, CEO of Reprocell added, ‘The Reprocell group of companies now offers products and services that span the 2D and 3D cell culture, stem cell culture media, iPSC-derived cells and human tissue samples. We can now help the global scientific community move their basic and pre-clinical research towards more sustainable and physiologically relevant models. Our customers can now move easily from testing monolayer culture to 3D culture to human tissue systems all with support from a single source.’


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Fighting Cancer with Sticky Nanoparticles
Treatment that uses bioadhesive nanoparticles drug carriers proved more effective than conventional treatments for certain cancers.
Stem Cell ‘Heart Patch’ Almost Perfected
Scientists aiming to perfect and test 3D "heart patches" in animal model, last hurdle before human patients.
Smart Material Hunts Cancers
Team has created smart material that locates and images cancer or tumour sites in tissue.
Targeting Fat to Treat Cancer
Researchers develop novel cancer treatment that halts fat synthesis in cells, stunting tumors.
Reprogramming Lymph Nodes to Fight MS
Bioengineers work to reprogram lymph node function to fight multiple sclerosis.
Arms Race with a Superbug
Scientists have discovered that increased risk of superbug infection can be directly casued by immune system response to invading bacteria.
Genes Essential to Life Discovered
Genes critical for life are discovered in humans and mice as part of large-scale phenotyping study.
High-Capacity Nanoparticles
New type of nanoparticle can now have three or more drugs packaged within it, allowing for customised cancer therapy.
Manipulation of Liquid Crystals Could Help Control Drug-Delivery Process
Computer modeling, real-world testing yields new method.
Puttng Cells Through Their Paces
An obstacle course for human lung cells could be the answer for better testing the effectiveness of potential new drugs.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!